Novartis reports clinically relevant improvement in median overall survival data in final analysis of pivotal NETTER-1 study with targeted radioligand therapy Lutathera
At final analysis, study showed clinically relevant improvement in median overall survival with a difference…
Embracing AI while Keeping an Eye Out for Fraud
ScienceLogic™ Cuts Complexity and Accelerates IT Performance with Skylar™ One Updates
Embracing the Three ‘R’s of Quantum
Stockman’s Casino Selects Quick Custom Intelligence Enterprise Platform